ストックスクリーナーアプリを入手
190.84
5.83%
-11.70
前日終値:
$202.54
開ける：
$199.88
24時間の取引高:
2.09M
Relative Volume:
1.49
時価総額：
$32.41B
収益：
$15.90B
当期純損益:
$1.28B
株価収益率:
26.20
EPS:
7.2842
ネットキャッシュフロー:
$2.21B
1週間 パフォーマンス:
-19.05%
1か月 パフォーマンス:
-18.69%
6か月 パフォーマンス:
+3.70%
1年 パフォーマンス:
-7.16%
1日の値動き範囲:
$182.41
$199.88
1週間の範囲:
$182.41
$234.87
52週間の値動き範囲:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
IQV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
190.34 | 34.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
554.43 | 212.36B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
217.87 | 155.19B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
647.66 | 51.34B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
131.64 | 37.70B | 6.95B | 1.30B | 1.15B | 4.5696 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-11-03 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-09-09 | アップグレード | Jefferies | Hold → Buy |
| 2025-04-25 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-12-20 | 開始されました | Stephens | Overweight |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-09-04 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-07-24 | ダウングレード | Jefferies | Buy → Hold |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-02-15 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-02-13 | 開始されました | BTIG Research | Buy |
| 2023-11-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-03-17 | 開始されました | Truist | Buy |
| 2022-12-06 | 開始されました | Cowen | Outperform |
| 2022-11-17 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-15 | 開始されました | SVB Leerink | Outperform |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-29 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-16 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2020-07-07 | 開始されました | Stephens | Equal-Weight |
| 2020-03-02 | 開始されました | Deutsche Bank | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-12-13 | アップグレード | CFRA | Sell → Hold |
| 2019-11-14 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | アップグレード | Mizuho | Neutral → Buy |
| 2019-05-28 | 開始されました | SVB Leerink | Outperform |
| 2019-01-18 | アップグレード | Jefferies | Hold → Buy |
| 2018-10-09 | 開始されました | UBS | Buy |
| 2018-10-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2018-07-25 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 繰り返されました | Stifel | Buy |
| 2018-07-03 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | アップグレード | Goldman | Neutral → Buy |
| 2018-03-07 | アップグレード | SunTrust | Hold → Buy |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Iqvia Holdings Inc (IQV) 最新ニュース
IQVIA's (IQV) 2026 Earnings Forecast Falls Short Amid Rising Int - GuruFocus
IQVIA forecasts weak annual profit on higher interest expenses - marketscreener.com
Real-World Data on Healthcare Technology Adoption: Company Insights and Government Trends with Key Statistics (e.g., 71% U.S. Hospitals Adoption, $3B Company Valuations) - GlobeNewswire Inc.
IQVIA Q4 2025 slides: Revenue jumps 10.3%, stock falls despite beat - Investing.com India
IQVIA stock slides after Q4 results on outlook (IQV:NYSE) - Seeking Alpha
Earnings call transcript: IQVIA Q4 2025 beats forecasts, stock drops - Investing.com
IQVIA Holdings Inc. Provides Earnings Guidance for Full Year 2026 - marketscreener.com
IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - pharmiweb.com
Iqvia shares down 6.48% after co forecasts 2026 profit below estimates - marketscreener.com
Iqvia (IQV) Q4 Revenue Surpasses Expectations with Strong Segmen - GuruFocus
IQV Announces 2026 Financial Projections with Strong Earnings Ou - GuruFocus
IQVIA Holdings Inc (NYSE:IQV) Beats Q4 Revenue Estimates and Issues 2026 Guidance - Chartmill
IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates - Yahoo! Finance Canada
(IQV) IQVIA Expects 2026 Adjusted EPS Range $12.55 to $12.85, vs. FactSet Est of $12.93 - marketscreener.com
IQVIA: Q4 Earnings Snapshot - kens5.com
IQV: Strong Q4 and 2025 results with positive 2026 outlook and strategic segment realignment - TradingView
A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Volatility - Yahoo Finance
IQVIA Holdings earnings on deck amid clinical research trends By Investing.com - Investing.com India
IQV or IDXX: Which Is the Better Value Stock Right Now? - sharewise.com
Earnings Outlook For IQVIA Hldgs - Benzinga
IQVIA Holdings earnings on deck amid clinical research trends - Investing.com
Value Recap: Is IQVIA Holdings Inc in a long term uptrend2025 Macro Impact & Fast Moving Market Watchlists - baoquankhu1.vn
IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Is IQVIA Holdings Inc stock influenced by commodity prices2025 Fundamental Recap & AI Enhanced Trading Signals - baoquankhu1.vn
IQVIA (NYSE:IQV) Shares Down 12.5%Time to Sell? - MarketBeat
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IQVIA Holdings Inc (IQV) Stock Price Down 9.18% on Feb 3 - GuruFocus
Agree To Purchase IQVIA Holdings At $165, Earn 6.4% Using Options - Nasdaq
IQVIA Set to Report Q4 Earnings: Here's What You Should Know - Yahoo Finance
Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
(IQV) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Running Oak Capital LLC Sells 8,331 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Is IQVIA Holdings stock outperforming the S&P 500? - MSN
A Closer Look At IQVIA Holdings Inc.'s (NYSE:IQV) Impressive ROE - Yahoo Finance
Mediolanum International Funds Ltd Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
National Pension Service Increases Position in IQVIA Holdings Inc. $IQV - MarketBeat
New York State Common Retirement Fund Reduces Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Aug Weekly: Is IQVIA Holdings Inc stock showing strong momentumQuarterly Portfolio Review & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Bank of New York Mellon Corp Purchases 20,385 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Ritter Daniher Financial Advisory LLC DE Acquires Shares of 4,267 IQVIA Holdings Inc. $IQV - MarketBeat
Truist Financial Corp Has $29.43 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Collaboration With Sarah Cannon Puts Clinical Trial Role In Focus - Sahm
Iqvia, Boehringer Ingelheim Form Long-Term Data Partnership to Power Global Commercial Analytics - marketscreener.com
Iqvia (IQV) Partners with Boehringer Ingelheim for Data Transfor - GuruFocus
Ruffer LLP Sells 104,917 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
How a new IQVIA–Boehringer data pact links drug sales across 59 countries - Stock Titan
J. Safra Sarasin Holding AG Trims Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA (IQV) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Market Leaders: Will Massimo Group face regulatory challengesGlobal Markets & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Kornitzer Capital Management Inc. KS Sells 29,966 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Accelerate your early phase clinical trial decisions - IQVIA
Iqvia Holdings Inc (IQV) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
0.05%
大文字化:
|
ボリューム (24 時間):